The walls of Anne Hansen’s office tell a story. The main character, medical director of the Neonatal Intensive Care Unit at Boston Children’s Hospital, is an innovator, a global citizen and respected neonatologist. Her life and work has benefitted newborns and parents, medical trainees and colleagues around the world.
Read more about her life, work and innovations by hovering over the objects that surround her every day.
Pick up a piece of IV tubing (should you happen to have one nearby) and run your hand down the length of it. The surface feels pretty smooth, yes?
From the perspective of bacteria and platelets, that same surface is pockmarked with nooks and crannies where they can stick, aggregate and start to form blood clots (in the case of platelets) or hard-to-combat biofilms (in the case of bacteria).
That’s a problem for hospital care. Contaminated central lines (IV lines threaded into deep veins for long periods of time) cause upwards of 41,000 costly and potentially fatal central line-associated bloodstream infections (CLABSIs) in pediatric and adult patients in U.S. hospitals every year. And blood clots can preclude patients, including premature babies, from receiving new lung-protecting treatments because they can’t tolerate anticoagulants.